IDEXX Laboratories Exceeds Expectations

For the second quarter in a row, animal diagnostics company IDEXX Laboratories (NASDAQ: IDXX) increased its revenue and earnings guidance. While other sectors of the economy are experiencing slower growth, IDEXX's core market -- companion animal diagnostics -- is growing nicely, and the company's 2015 shift to a direct sales model continues to generate impressive sales increases. Let's take a look at the details behind a good quarter of execution.

Continue Reading Below

IDEXX Laboratories has good long term prospects thanks to spending trends on companion animals. Image source: Getty Images.

IDEXX Laboratories second-quarter results: The raw numbers

Starting with the headline numbers:

<3>More From

Continue Reading Below